key: cord-0868135-iagl31sf
authors: Gachari, Maryanne N.; Ndegwa, Linus; Emukule, Gideon O.; Kirui, Lily; Kalani, Rosalia; Juma, Bonventure; Mayieka, Lilian; Kinuthia, Peter; Widdowson, Marc‐Alain; Chaves, Sandra S.
title: Severe acute respiratory illness surveillance for influenza in Kenya: Patient characteristics and lessons learnt
date: 2022-03-14
journal: Influenza Other Respir Viruses
DOI: 10.1111/irv.12979
sha: df75fae279cc77d3218da4a98f53f6645617baeb
doc_id: 868135
cord_uid: iagl31sf

BACKGROUND: We describe the epidemiology and clinical features of Kenyan patients hospitalized with laboratory‐confirmed influenza compared with those testing negative and discuss the potential contribution of severe acute respiratory illness (SARI) surveillance in monitoring a broader range of respiratory pathogens. METHODS: We described demographic and clinical characteristics of SARI cases among children (<18 years) and adults, separately. We compared disease severity (clinical features and treatment) of hospitalized influenza positive versus negative cases and explored independent predictors of death among SARI cases using a multivariable logistic regression model. RESULTS: From January 2014 to December 2018, 11,166 persons were hospitalized with SARI and overall positivity for influenza was ~10%. There were 10,742 (96%) children (<18 years)—median age of 1 year, interquartile range (IQR = 6 months, 2 years). Only 424 (4%) of the SARI cases were adults (≥18 years), with median age of 38 years (IQR 28 years, 52 years). There was no difference in disease severity comparing influenza positive and negative cases among children. Children hospitalized with SARI who had an underlying illness had greater odds of in‐hospital death compared with those without (adjusted odds ratio 2.11 95% CI 1.09–4.07). No further analysis was done among adults due to the small sample size. CONCLUSION: Kenya's sentinel surveillance for SARI mainly captures data on younger children. Hospital‐based platforms designed to monitor influenza viruses and associated disease burden may be adapted and expanded to other respiratory viruses to inform public health interventions. Efforts should be made to capture adults as part of routine respiratory surveillance.

Globally, each year, influenza epidemics result in 3 to 5 million cases of severe illness and approximately 290,000 to 650,000 influenzarelated deaths. 1 A recent modeling study estimated that the highest burden of annual influenza-related deaths was in Sub-Saharan Africa, South East Asia, and Western Pacific regions. 2 The rate of severe disease is highest in young children <2 years, adults ≥65 years, pregnant women, and individuals with underlying chronic medical conditions. 3, 4 In temperate areas, there are distinct influenza seasons during the cold months, but in the tropics, influenza circulates year-round, with multiple, often erratic, periods of increased influenza activity, 5 a pattern also seen in Kenya. 6 Due to increased globalization, respiratory disease pandemics are likely to spread widely fast, as seen currently with the COVID-19 pandemic. 7 In 2006, in response to the pandemic threat of avian influenza A (H5N1), influenza surveillance in Sub-Saharan Africa was expanded. 8 Since then, data collected through clinical and virologic surveillance in Africa have contributed to the description of influenza seasonality, characterized genetic make-up of circulating viruses, and provided viruses for vaccine production. 9 In Kenya, influenza sentinel surveillance has been ongoing since 2007 (2008) and over the years has evolved to focus exclusively on hospitalized cases. This paper aims to describe the epidemiology and clinical features of patients hospitalized with influenza in Kenya and highlight the importance of yearround surveillance for severe acute respiratory infections (SARI), especially in tropical countries. 

Trained surveillance officers at each surveillance site identified patients with any signs or symptoms of acute respiratory illness by review of inpatient ward admission registers (new admissions on Monday reviewing those admitted during the weekend and Tuesday through Friday to capture new admissions). The surveillance officers approached all potential patients to assess eligibility, specifically if the patient met the case definition for SARI defined as history of fever (or measured fever of ≥38C ) and cough, with onset of symptoms within 10 days prior to hospitalization.

Patients who met the SARI surveillance case definition were approached for verbal consent, and once consent had been obtained, the surveillance officers assigned a unique number to the patient and interviewed either the patient or guardian using an electronic structured questionnaire stored on a password-protected netbook. Data were collected on demographic and clinical characteristics of patients, including underlying conditions and medical history. A follow-up exit questionnaire was completed for each patient by abstracting data on clinical outcomes of hospitalization from medical charts upon discharge, death, or transfer. All data were stored on a secure central server maintained by the Kenya Medical and Research Institute (KEMRI). No personal identifiers were stored in the data base. 

An aliquot of each specimen was tested by real-time reverse transcription polymerase chain reaction (rtRT-PCR) for influenza virus types A and B at the NIC, using protocol, primers, and probes provided by the Influenza Division, CDC-Atlanta, USA, as previously described. 10 Briefly, total ribonucleic acid (RNA) was extracted from 140 mL aliquots of each specimen using a QIAamp viral RNA mini kit (Qiagen GmbH, Germany) according to the manufacturer's instructions. One-step rtRT-PCR was carried out using the AgPath kit (Applied Biosystems, California, USA). Values with a cyclic threshold (C T ) reading <40 were recorded as positive. All specimens positive for influenza type A were subtyped for H3 and pH1N1 using rtRT-PCR.

Specimens that were positive for influenza A virus by rtRT-PCR but failed to subtype were sent to the WHO Influenza Collaborating Center at CDC-Atlanta, GA, USA, for further antigenic characterization. Because children and adults would likely differ in risk factors and severity, the analysis was done separately for children (<18 years) and adults. We used proportions to describe the demographic and clinical characteristics of SARI cases separately for adults and children. We compared influenza positive cases with those testing influenza negative, for children only due to limited sample size among adults, using Chi-square test statistic (or Fisher's exact test if applicable) for various demographic, clinical characteristics, and outcomes. Children with no recorded laboratory result were excluded from this analysis. We assessed the severity of disease among children by comparing clinical and treatment characteristics (tachypnea, hypoxia, high fever, intravenous fluids and blood transfusion treatment, admission to intensive care unit [ICU], and death) among influenza positive cases and those testing negative. We used graphs to display trends of influenza positivity for hospitalized children with SARI who were tested for influenza in the 5-year period and showed the types and subtypes detected. Those who had absconded care or refused treatment were excluded as their outcome status could not be confirmed. We then pre-selected variables that were potential confounders (age, sex, length of time from illness onset to hospitalization, and any chronic illness) or with a p value of <0.2 to include in a multivariable logistic regression model to assess predictors of death. Variables that had a p value of <0.05 in the final model were considered statistically significant.

Data from this surveillance were regarded by the Kenya MOH as a routine public health activity and received a non-research project determination by CDC and thus did not require an ethical review. Verbal consent was obtained from all participants before administration of questionnaires and collection of specimens. For children, verbal consent was obtained from the parent/guardian and assent for children ≥7 years. (53.2%) were aged 6-23 months, and 5979 (55.6%) were males. Hospitalizations associated with SARI among adults mostly represented F I G U R E 1 Sentinel surveillance sites for severe acute respiratory illness (SARI) in Kenya people 18-64 years (85%), and 61.8% of all adults hospitalized were males. The median age among adults was 38 years (IQR = 28 years, 52 years). Underlying medical conditions were present among 2142 (19.9%) children and 214 (50.4%) among adult SARI cases. The overall influenza positivity among samples tested from two thirds of children and adults was comparable (10.0% and 11.7%, respectively) ( Table 1) .

There were 716 (10.0%) children with laboratory confirmed influenza.

Because the number of adult cases was limited, the rest of the analysis was focused only on children from this point forward.

When comparing children with influenza and those without, there were significant differences observed by age group (p < 0.001); the <6 months age group was underrepresented among influenza positive cases compared with influenza negative (9.5% vs. 21.1%). Nonetheless, most clinical outcomes and severity were similar, with a small difference in the time from disease onset to hospitalization where influenza negative cases seem to be hospitalized earlier in the course of the disease compared with influenza positive cases (68.8% vs. 63.3%, respectively; p value <0.001), and a lower frequency of tachypnea was reported among the influenza positive cases (36.0% vs. 43.8%; p < 0.001) ( Table 2) .

Overall, the median influenza positivity rate of SARI samples tested for the entire period was 7% (IQR = 3.6%-13.9%), with the highest positivity rate of 23% detected in July 2018. There was not any clear pattern of seasonality observed ( Figure 2 ). Overall, highest percentage of influenza positivity was in those aged 5-17 years (16%; 95% CI 12.6, 19.5) and 2-4 years (15%; 95% CI 13.0, 16.6). The temporal distribution of the types and subtypes of influenza viruses among children that were detected during the study period is shown in (supporting information Figure S1 ).

Overall, there was no significant difference in the CFP between hospitalized children who tested positive for influenza (3.3%, 95% CI 1.9, 4.5) and those who tested negative (3.6%, 95% CI 3.2, 4.2). Young children aged less than 6 months who were influenza positive had a higher but not statistically significant CFP of 8.8% (95% CI 2.1, 15.6) compared with 4.7% (95% CI 4.7 3.5, 5.8) among those who tested negative ( Figure 3 ). No notable differences were observed among older children (6-23 months and 2-4 years). Influenza positive SARI cases who were hospitalized >7 days after illness onset had a higher but not statistically significant CFP of 11.9% (95% CI 3.9, 25.6) compared with 2.9% (95% CI 1.6, 4.9) among those hospitalized early (<4 days from illness onset). Tuberculosis significantly increased CFP in both influenza positive and negative groups: 20% (95% CI 0. 5 Adults may be more likely to delay healthcare seeking, 13 Approximately one tenth of children hospitalized with SARI tested positive for influenza, similar to results from other surveillance sites in Sub-Saharan Africa like Rwanda (6.3%), 15 Zambia (5.5%), 16 Malawi (11.3%), 17 and South Africa (7.3%). 18 This suggests that there is a high rate of other respiratory illness etiologies that could explain some of the hospitalizations associated with cough and fever. Broader testing could allow for identification of common and emerging respiratory pathogens as well as monitoring the impact of public health inter- South Africa (3%) 20 and Egypt (2%). 21 The overall CFP in influenza- 

The authors have no conflict of interest to disclose. 

The peer review history for this article is available at https://publons. 

Influenza (seasonal).int/en/news

Estimates of global seasonal influenza-associated respiratory mortality: A modelling study

Identification of children at risk of influenza-related complications in primary and ambulatory care: A systematic review and meta-analysis

Population-based study on incidence, risk factors, clinical complications and drug utilisation associated with influenza in the United Kingdom

Influenza seasonality in the tropics and subtropics-When to vaccinate?

Timing, association with climatic factors, and implications for vaccination campaigns

Three months of COVID-19: A systematic review and meta-analysis

Influenza surveillance in 15 countries in Africa

WHO. WHO epidemiological influenza surveillance standards

Results from the first six years of national sentinel surveillance for influenza in Kenya

Complicated hospitalization due to influenza: Results from the Global Hospital Influenza Network for the 2017-2018 season

Kenya health financing system assessment

Kenya Household Health Expenditure and

Influenza surveillance case definitions miss a substantial proportion of older adults hospitalized with laboratory-confirmed influenza: A report from the Canadian Immunization Research Network (CIRN) Serious Outcomes Surveillance (SOS) Network

The national burden of influenza-associated severe acute respiratory illness hospitalization in Rwanda

The national burden of influenzaassociated severe acute respiratory illness hospitalization in Zambia

Respiratory virusassociated severe acute respiratory illness and viral clustering in Malawian children in a setting with a high prevalence of HIV infection, malaria, and malnutrition

Risk factors associated with hospitalisation for influenza-associated severe acute respiratory illness in South Africa: A case-population study

WHO_Europe _ 2019-2020 influenza season_ repurposing surveillance systems for COVID-19

Mortality amongst patients with influenza-associated severe acute respiratory illness

Mortality, and seasonality of influenza hospitalizations in Egypt

Severe acute respiratory illness deaths in Sub-Saharan Africa and the role of influenza: A case series from 8 countries

The global influenza Initiative recommendations for the vaccination of pregnant women against seasonal influenza

Severe influenza-associated respiratory infection in high HIV prevalence setting, South Africa

Risk factors for influenzaassociated severe acute respiratory illness hospitalization in South Africa

Influenza-associated morbidity and mortality in Sub-Saharan Africa

School-located influenza vaccination decreases laboratory-confirmed influenza and improves school attendance

Understanding reasons for participating in a school-based influenza vaccination program and decision-making dynamics among adolescents and parents

Assessing optimal target populations for influenza vaccination programmes: An evidence synthesis and modelling study

National burden of hospitalized and non-hospitalized influenza-associated severe acute respiratory illness in Kenya

Severe acute respiratory illness surveillance for influenza in Kenya: Patient characteristics and lessons learnt

Maryanne N. Gachari https://orcid.org/0000-0001-7707-2369